ECSP088340A - Procesos para la síntesis de los compuestos para inhibición de selectina - Google Patents

Procesos para la síntesis de los compuestos para inhibición de selectina

Info

Publication number
ECSP088340A
ECSP088340A EC2008008340A ECSP088340A ECSP088340A EC SP088340 A ECSP088340 A EC SP088340A EC 2008008340 A EC2008008340 A EC 2008008340A EC SP088340 A ECSP088340 A EC SP088340A EC SP088340 A ECSP088340 A EC SP088340A
Authority
EC
Ecuador
Prior art keywords
compounds
synthesis
processes
selectin
selectin inhibition
Prior art date
Application number
EC2008008340A
Other languages
English (en)
Inventor
Youchu Wang
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ECSP088340A publication Critical patent/ECSP088340A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/473Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/10Aza-phenanthrenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Las presentes enseñanzas se relacionan con el campo de sustancias antiinflamatorias, y más particularmente con la preparación de los compuestos que actúan como antagonistas de las proteínas de adhesión de mamíferos conocidas como selectinas. En algunas modalidades, las actuales enseñanzas proporcionan métodos para preparar compuestos para tratar trastornos mediados por selectina que tienen la fórmula VI, en donde R1, R2, R3, p, y q se definen aquí.
EC2008008340A 2005-10-05 2008-04-02 Procesos para la síntesis de los compuestos para inhibición de selectina ECSP088340A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72373405P 2005-10-05 2005-10-05

Publications (1)

Publication Number Publication Date
ECSP088340A true ECSP088340A (es) 2008-06-30

Family

ID=37672216

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008340A ECSP088340A (es) 2005-10-05 2008-04-02 Procesos para la síntesis de los compuestos para inhibición de selectina

Country Status (19)

Country Link
US (1) US20070082923A1 (es)
EP (1) EP1931638A1 (es)
JP (1) JP2009511488A (es)
KR (1) KR20080053389A (es)
CN (1) CN101277936A (es)
AR (1) AR058079A1 (es)
AU (1) AU2006302375A1 (es)
BR (1) BRPI0616906A2 (es)
CA (1) CA2624552A1 (es)
CR (1) CR9854A (es)
EC (1) ECSP088340A (es)
GT (1) GT200600447A (es)
IL (1) IL190435A0 (es)
NO (1) NO20081548L (es)
PE (1) PE20070590A1 (es)
RU (1) RU2008112191A (es)
TW (1) TW200738639A (es)
WO (1) WO2007044475A1 (es)
ZA (1) ZA200802990B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2134692A2 (en) * 2007-03-30 2009-12-23 Wyeth a Corporation of the State of Delaware Quinoline derivatives and pharmaceutical compositions comprising them for selectin inhibition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239280B1 (en) * 1999-06-30 2001-05-29 Merck & Co., Inc. Process for synthesizing biaryl inhibitors of farnesyl-protein transferase
TW200522954A (en) * 2003-11-10 2005-07-16 Wyeth Corp Methods and compositions for selectin inhibition

Also Published As

Publication number Publication date
RU2008112191A (ru) 2009-11-10
CA2624552A1 (en) 2007-04-19
JP2009511488A (ja) 2009-03-19
CR9854A (es) 2008-05-21
EP1931638A1 (en) 2008-06-18
NO20081548L (no) 2008-04-28
AR058079A1 (es) 2008-01-23
IL190435A0 (en) 2008-11-03
PE20070590A1 (es) 2007-07-11
ZA200802990B (en) 2008-12-31
WO2007044475A1 (en) 2007-04-19
KR20080053389A (ko) 2008-06-12
AU2006302375A1 (en) 2007-04-19
CN101277936A (zh) 2008-10-01
TW200738639A (en) 2007-10-16
GT200600447A (es) 2007-05-08
US20070082923A1 (en) 2007-04-12
BRPI0616906A2 (pt) 2011-07-05

Similar Documents

Publication Publication Date Title
DOP2011000237A (es) Inhibidores de poli (adp-ribosa) polimerasa (parp)
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
CR20110028A (es) Derivados de pirimidina como inhibidores de cinasa
UY30500A1 (es) Compuestos de azabencimidazolilo
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
MX388468B (es) Compuestos multicíclicos y métodos de uso de los mismos.
CR11861A (es) Compuestos organicos
EA201000642A1 (ru) 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы
GT200600346A (es) Nueva fórmula cristalina v de la agomelatina, un proceso para su preparación y composiciones farmacéuticas que la contienen
UY30141A1 (es) Nuevas isoindolonas potenciadoras de receptores metabotropicos de glutamato
ECSP078055A (es) Formas sólidas cristalinas de tigeciclina y métodos para preparar las mismas
MX2019008122A (es) Derivados de aminas heterociclicas que inhiben la transduccion de se?al mediada por cinasa asociada con el receptor de interleucina-1.
EA200901609A1 (ru) Амиды пиразолкарбоновой кислоты, применимые в качестве микробиоцидов
CO6491116A2 (es) Derivados de 5-fluoropirimidinona
CL2010001348A1 (es) Compuestos derivados de 1-oxo-2,3-dihidro-1h-isoindolin-5-il)-isoxazol-3-carboxamida, potenciadores de los mglur2; composicion farmaceutica; y su uso para aliviar los sintomas o disminuir la aparicion de los sintomas de ezquizofrenia o ansiedad.
CL2007001711A1 (es) Compuestos derivados de pirazolopiridina sustituida;composicion farmaceutica que los comprende;metodo de preparacion de los compuestos ,compuestos intermediarios;y su uso en el tratamiento de enfermedades,tales como tumores,artritis reumatoide,enfermedades del crecimiento vascular desregulado, entre otras.
UY32704A (es) Compuestos de 2,3-dihidro-1h-indeno
NI201100096A (es) Lactamas como inhibidores de beta secretasa.
EA201101097A1 (ru) Новые микробиоциды
GT200600117A (es) Nuevos compuestos farmaceuticos
ECSP066557A (es) Métodos y composiciones para inhibición de selectina
CR8384A (es) Metodos y composiciones para la inhibicion de selectina
ECSP088340A (es) Procesos para la síntesis de los compuestos para inhibición de selectina
UY31423A1 (es) Compuestos de indolina
UY28911A1 (es) Profármacos de esteroides con acción androgénica